← Back to all recalls
FDA RECALL ALERT
Aisling Doxorubicin Hydrochloride Liposome Injection
Sun Pharma is recalling Aisling Doxorubicin Hydrochloride Liposome Injection 50mg/25 mL nationwide due to potential glass particle contamination.
What to do
Stop using the product immediately and contact Inmar Inc. at 855-745-9357 or rxrecalls@inmar.com for recall instructions.
Why it was recalled
Sun Pharma is recalling Aisling Doxorubicin Hydrochloride Liposome Injection 50mg/25 mL distributed nationwide due to the potential presence of glass particles in the product.
How to identify it
Aisling Doxorubicin Hydrochloride Liposome Injection, 50mg/25 mL
Official source
Editorial summary by Recall Canary · last updated 2026-05-13 · primary source: U.S. Food and Drug Administration